Can #Bayer recover from its chronic pain? Last year the Aspirin-maker made a net loss of almost $3.2bn. Sales fell by 6%. It has torched 70% in shareholder value since June 2018, when it completed its acquisition of #Monsanto. How to undo that deal’s toxic legacy? www.economist.com/business/202...
Can Bayer recover from its chronic pain?
The Aspirin-maker is suffering from complications of its acquisition of Monsanto
www.economist.com